NXTCL (NXTCL) News
Track canonical SquawkNews coverage tagged to NXTCL, NXTCL. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
NextCell Pharma (Q2 review): Just ahead of Phase ll readout
NextCell Pharma (Q2 review): Just ahead of Phase ll readout
EQUITY | Aug 28, 2026, 09:19 AM UTC
L
Nextcell Pharma reports Q2 2026 operating income of SEK 3.0 mln
Nextcell Pharma said Q2 2026 operating income was SEK 3.0 million.
EARNINGS | Aug 27, 2026, 05:33 AM UTC
L
NXTCL reports operating income doubled; first commercial product launched
NXTCL said operating income doubled and it launched its first commercial product, while awaiting pivotal clinical data.
EQUITY | Aug 27, 2026, 05:32 AM UTC